Collagen type IV-specific tripeptides for selective adhesion of endothelial and smooth muscle cells

Kei Kanie, Yuji Narita, Yingzi Zhao, Fumiaki Kuwabara, Makoto Satake, Susumu Honda, Hiroaki Kaneko, Tomohiko Yoshioka, Mina Okochi, Hiroyuki Honda, Ryuji Kato

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Controlling the balance of endothelial cells (ECs) and smooth muscle cells (SMCs) in blood vessels is critically important to minimize the risk associated with vascular implants. Extracellular matrix (ECM) plays a key role in controlling the cellular balance, suggesting a promising source of cell-selective peptides. To obtain EC- or SMC-selective peptides, we start by highlighting sequence differences found among ECM molecules as enriched targets for cell-selective peptides. We explored the EC- or SMC-selective performance of tripeptides that are specifically enriched only in collagen type IV, but not in types I, II, III, and V. Collagen type IV was chosen since it is the major ECM in the basement membrane of blood vessels, which separates ECs and SMCs. Among 114 collagen type IV-derived tripeptides pre-screened from in silico analysis, 22 peptides (19%) were found to promote cell-selective adhesion, as determined by peptide array. One of the best performing EC-selective peptides (Cys-Ala-Gly (CAG)) was mixed into an electrospun fine-fiber, a vascular graft material, for practical application. Compared to unmodified fiber, the CAG containing fiber surface was found to enhance adhesion of ECs (+190%) while limiting SMCs (-20%). These results are not only consistent with the hypothesis of ECM as a source of cell selective peptides, but also suggest a new genre of EC- or SMC-selective peptides for tissue engineering applications. Collectively, these findings favorably support the screening approach used to discover new peptides for these purposes.

Original languageEnglish
Pages (from-to)1808-1816
Number of pages9
JournalBiotechnology and Bioengineering
Volume109
Issue number7
DOIs
Publication statusPublished - Jul 2012
Externally publishedYes

Fingerprint

Collagen Type IV
Collagen
Peptides
Smooth Muscle Myocytes
Muscle
Endothelial cells
Adhesion
Cells
Endothelial Cells
Extracellular Matrix
Blood Vessels
Blood vessels
Fibers
Tissue Engineering
Tissue engineering
Basement Membrane
Cell Adhesion
Grafts
Computer Simulation
Screening

Keywords

  • Cell selective peptide
  • Collagen
  • Endothelial cell
  • Extracellular matrix (ECM)
  • Smooth muscle cell

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology

Cite this

Kanie, K., Narita, Y., Zhao, Y., Kuwabara, F., Satake, M., Honda, S., ... Kato, R. (2012). Collagen type IV-specific tripeptides for selective adhesion of endothelial and smooth muscle cells. Biotechnology and Bioengineering, 109(7), 1808-1816. https://doi.org/10.1002/bit.24459

Collagen type IV-specific tripeptides for selective adhesion of endothelial and smooth muscle cells. / Kanie, Kei; Narita, Yuji; Zhao, Yingzi; Kuwabara, Fumiaki; Satake, Makoto; Honda, Susumu; Kaneko, Hiroaki; Yoshioka, Tomohiko; Okochi, Mina; Honda, Hiroyuki; Kato, Ryuji.

In: Biotechnology and Bioengineering, Vol. 109, No. 7, 07.2012, p. 1808-1816.

Research output: Contribution to journalArticle

Kanie, K, Narita, Y, Zhao, Y, Kuwabara, F, Satake, M, Honda, S, Kaneko, H, Yoshioka, T, Okochi, M, Honda, H & Kato, R 2012, 'Collagen type IV-specific tripeptides for selective adhesion of endothelial and smooth muscle cells', Biotechnology and Bioengineering, vol. 109, no. 7, pp. 1808-1816. https://doi.org/10.1002/bit.24459
Kanie, Kei ; Narita, Yuji ; Zhao, Yingzi ; Kuwabara, Fumiaki ; Satake, Makoto ; Honda, Susumu ; Kaneko, Hiroaki ; Yoshioka, Tomohiko ; Okochi, Mina ; Honda, Hiroyuki ; Kato, Ryuji. / Collagen type IV-specific tripeptides for selective adhesion of endothelial and smooth muscle cells. In: Biotechnology and Bioengineering. 2012 ; Vol. 109, No. 7. pp. 1808-1816.
@article{9f5a071882c6427fb199fb64368a350b,
title = "Collagen type IV-specific tripeptides for selective adhesion of endothelial and smooth muscle cells",
abstract = "Controlling the balance of endothelial cells (ECs) and smooth muscle cells (SMCs) in blood vessels is critically important to minimize the risk associated with vascular implants. Extracellular matrix (ECM) plays a key role in controlling the cellular balance, suggesting a promising source of cell-selective peptides. To obtain EC- or SMC-selective peptides, we start by highlighting sequence differences found among ECM molecules as enriched targets for cell-selective peptides. We explored the EC- or SMC-selective performance of tripeptides that are specifically enriched only in collagen type IV, but not in types I, II, III, and V. Collagen type IV was chosen since it is the major ECM in the basement membrane of blood vessels, which separates ECs and SMCs. Among 114 collagen type IV-derived tripeptides pre-screened from in silico analysis, 22 peptides (19{\%}) were found to promote cell-selective adhesion, as determined by peptide array. One of the best performing EC-selective peptides (Cys-Ala-Gly (CAG)) was mixed into an electrospun fine-fiber, a vascular graft material, for practical application. Compared to unmodified fiber, the CAG containing fiber surface was found to enhance adhesion of ECs (+190{\%}) while limiting SMCs (-20{\%}). These results are not only consistent with the hypothesis of ECM as a source of cell selective peptides, but also suggest a new genre of EC- or SMC-selective peptides for tissue engineering applications. Collectively, these findings favorably support the screening approach used to discover new peptides for these purposes.",
keywords = "Cell selective peptide, Collagen, Endothelial cell, Extracellular matrix (ECM), Smooth muscle cell",
author = "Kei Kanie and Yuji Narita and Yingzi Zhao and Fumiaki Kuwabara and Makoto Satake and Susumu Honda and Hiroaki Kaneko and Tomohiko Yoshioka and Mina Okochi and Hiroyuki Honda and Ryuji Kato",
year = "2012",
month = "7",
doi = "10.1002/bit.24459",
language = "English",
volume = "109",
pages = "1808--1816",
journal = "Biotechnology and Bioengineering",
issn = "0006-3592",
publisher = "Wiley-VCH Verlag",
number = "7",

}

TY - JOUR

T1 - Collagen type IV-specific tripeptides for selective adhesion of endothelial and smooth muscle cells

AU - Kanie, Kei

AU - Narita, Yuji

AU - Zhao, Yingzi

AU - Kuwabara, Fumiaki

AU - Satake, Makoto

AU - Honda, Susumu

AU - Kaneko, Hiroaki

AU - Yoshioka, Tomohiko

AU - Okochi, Mina

AU - Honda, Hiroyuki

AU - Kato, Ryuji

PY - 2012/7

Y1 - 2012/7

N2 - Controlling the balance of endothelial cells (ECs) and smooth muscle cells (SMCs) in blood vessels is critically important to minimize the risk associated with vascular implants. Extracellular matrix (ECM) plays a key role in controlling the cellular balance, suggesting a promising source of cell-selective peptides. To obtain EC- or SMC-selective peptides, we start by highlighting sequence differences found among ECM molecules as enriched targets for cell-selective peptides. We explored the EC- or SMC-selective performance of tripeptides that are specifically enriched only in collagen type IV, but not in types I, II, III, and V. Collagen type IV was chosen since it is the major ECM in the basement membrane of blood vessels, which separates ECs and SMCs. Among 114 collagen type IV-derived tripeptides pre-screened from in silico analysis, 22 peptides (19%) were found to promote cell-selective adhesion, as determined by peptide array. One of the best performing EC-selective peptides (Cys-Ala-Gly (CAG)) was mixed into an electrospun fine-fiber, a vascular graft material, for practical application. Compared to unmodified fiber, the CAG containing fiber surface was found to enhance adhesion of ECs (+190%) while limiting SMCs (-20%). These results are not only consistent with the hypothesis of ECM as a source of cell selective peptides, but also suggest a new genre of EC- or SMC-selective peptides for tissue engineering applications. Collectively, these findings favorably support the screening approach used to discover new peptides for these purposes.

AB - Controlling the balance of endothelial cells (ECs) and smooth muscle cells (SMCs) in blood vessels is critically important to minimize the risk associated with vascular implants. Extracellular matrix (ECM) plays a key role in controlling the cellular balance, suggesting a promising source of cell-selective peptides. To obtain EC- or SMC-selective peptides, we start by highlighting sequence differences found among ECM molecules as enriched targets for cell-selective peptides. We explored the EC- or SMC-selective performance of tripeptides that are specifically enriched only in collagen type IV, but not in types I, II, III, and V. Collagen type IV was chosen since it is the major ECM in the basement membrane of blood vessels, which separates ECs and SMCs. Among 114 collagen type IV-derived tripeptides pre-screened from in silico analysis, 22 peptides (19%) were found to promote cell-selective adhesion, as determined by peptide array. One of the best performing EC-selective peptides (Cys-Ala-Gly (CAG)) was mixed into an electrospun fine-fiber, a vascular graft material, for practical application. Compared to unmodified fiber, the CAG containing fiber surface was found to enhance adhesion of ECs (+190%) while limiting SMCs (-20%). These results are not only consistent with the hypothesis of ECM as a source of cell selective peptides, but also suggest a new genre of EC- or SMC-selective peptides for tissue engineering applications. Collectively, these findings favorably support the screening approach used to discover new peptides for these purposes.

KW - Cell selective peptide

KW - Collagen

KW - Endothelial cell

KW - Extracellular matrix (ECM)

KW - Smooth muscle cell

UR - http://www.scopus.com/inward/record.url?scp=84862824604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862824604&partnerID=8YFLogxK

U2 - 10.1002/bit.24459

DO - 10.1002/bit.24459

M3 - Article

C2 - 22359201

AN - SCOPUS:84862824604

VL - 109

SP - 1808

EP - 1816

JO - Biotechnology and Bioengineering

JF - Biotechnology and Bioengineering

SN - 0006-3592

IS - 7

ER -